TP53 and neoplasm: Tumors harboring TP53 missense mutations (n = 2167/7574; 28.6%) were significantly associated with decreased overall survival (p = 1.22e–15; Fig. 1A, right) compared to tumors without TP53 missense mutations, also suggesting that TP53 missense mutations function in tumor progression.